Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 323420Generated: November 1, 2026

2-Methoxy-5-(5-methylsulfonyltetrazol-1-yl)benzoic acid → 1-(2-methoxy-5-(5-methylsulfonyltetrazol-1-yl)benzoyl)-3-(2-(4-(1-(2-ethoxyethyl)-1H-benzimidazol-2-yl-amino)piperidin-1-yl)ethyl)-3-phenylpyrrolidine

https://huagongshe.com/reaction/323420

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-Methoxy-5-(5-methylsulfonyltetrazol-1-yl)benzoic acidHCID 18464438—
Reactant3-(2-(4-(1-(2-ethoxyethyl)-1H-benzimidazol-2-yl-amino)piperidin-1-yl)ethyl)-3-phenylpyrrolidine hydrochloric acid saltHCID 22009099—
Product1-(2-methoxy-5-(5-methylsulfonyltetrazol-1-yl)benzoyl)-3-(2-(4-(1-(2-ethoxyethyl)-1H-benzimidazol-2-yl-amino)piperidin-1-yl)ethyl)-3-phenylpyrrolidineHCID 20642248—

Reaction Steps

Prepare by the method of Example 59.1 using 2-methoxy-5-(5-methylsulfonyltetrazol-1-yl)benzoic acid and 3-(2-(4-(1-(2-ethoxyethyl)-1H-benzimidazol-2-yl-amino)piperidin-1-yl)ethyl)-3-phenylpyrrolidine hydrochloric acid salt (prepared from (−)-3-phenyl-3-(2-hydroxyethyl)pyrrolidine (R,R)-di-p-anisoyltartaric acid salt) to give the title compound.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06211199B1
Source datasetuspto-grants-2001_04
ORD IDord-194c8ad9daf64fb0acff5b5887400110
Source noteuspto-grants-2001_04